Vor Biopharma Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$371.6 | -$121.2 | -$126.0 | -$93.4 | -$69.0 |
| Net income | -$696.0 | -$116.9 | -$117.9 | -$92.1 | -$68.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$143.7 | -$99.9 | -$101.4 | -$93.6 | -$73.0 |
| Dividends | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
Shares outstanding 59.2M · Free float 30.9%
Annual filing data through FY ended December 31, 2025; float as of October 5, 2026.